Apolipoprotein E (ApoE) peptide regulates tau phosphorylation via two different signaling pathways

Journal of Neuroscience Research

Volumn 51, Issue 5, 1998, Pages 658-665

  Wang, Xiao Shu ^a   Luebbe, Patricia ^a   Gruenstein, Eric ^a   Zemlan, Frank ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

Apolipoprotein E; Cytoplasmic calcium; G protein; Neurons; Protein phosphatase; Tau

Indexed keywords

APOLIPOPROTEIN E; CALCIUM; CALCIUM CHANNEL; CYCLOSPORIN A; GUANINE NUCLEOTIDE BINDING PROTEIN; MONOCLONAL ANTIBODY; OKADAIC ACID; PEPTIDE; PERTUSSIS TOXIN; PHOSPHOPROTEIN PHOSPHATASE INHIBITOR; SERINE; TAU PROTEIN; TAUTOMYCIN; THREONINE;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DEPHOSPHORYLATION; EMBRYO; ENZYME LINKED IMMUNOSORBENT ASSAY; NERVE CELL CULTURE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; SIGNAL TRANSDUCTION;

AMINO ACID SEQUENCE; ANIMALS; ANTIBIOTICS, ANTIFUNGAL; ANTIBODIES, MONOCLONAL; APOLIPOPROTEINS E; CALCIUM; CYCLOSPORINE; CYTOPLASM; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; ENZYME-LINKED IMMUNOSORBENT ASSAY; IMMUNOSUPPRESSIVE AGENTS; MOLECULAR SEQUENCE DATA; NEURONS; OKADAIC ACID; PEPTIDE FRAGMENTS; PHOSPHORIC MONOESTER HYDROLASES; PHOSPHORYLATION; PYRANS; RATS; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION; SPIRO COMPOUNDS; TAU PROTEINS; TIME FACTORS; VIRULENCE FACTORS, BORDETELLA;

EID: 0032031784     PISSN: 03604012     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4547(19980301)51:5<658::AID-JNR13>3.0.CO;2-Z     Document Type: Article

References (45)

1. Bellosta S, Nathan BP, Orth M, Dong L-M, Mahley RW, Pitas RE (1995): Stable expression and secretion of apolipoproteins E3 and E4 in mouse neuroblastoma cells produces differential effects on neurite outgrowth. J Biol Chem 270:27063-27071.
2. Clay MA, Anantharamaiah GM, Mistry MJ, Balasubramaniam A, Harmony JAK (1995): Localization of a domain in apolipoprotein E with both cytostatic and cytotoxic activity. Biochemistry 34:11142-11151.
3. Cohen P (1989): The structure and regulation of protein phosphatases. Ann Rev Biochem 58:453-508.
4. Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Small GW, Roses AD, Haines JL, Pericak-Vance MA (1993): Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 261:921-923.
5. Crutcher KA, Clay MA, Scott SA, Tian X, Tolar M, Harmony JAK (1994): Neurite degeneration elicited by apolipoprotein E peptides. Exp Neurol 130:120-126.
6. Davis DR, Brion J-P, Couck A-M, Gallo J-M, Hanger DP, Ladhani K, Lewis C, Miller CCJ, Rupniak T, Smith C, Anderton BH (1995): The phosphorylation slate of the microtubule-associated protein tau as affected by glutamate, colchicine and β-amyloid in primary rat cortical neuronal cultures. Biochem J 309:941-949.
7. Dyer CA, Curtiss LK (1991): A synthetic peptide mimic of plasma apolipoprotein E that binds the LDL receptor. J Biol Chem 266:22803-22806.
8. Elshoubragy NA, Liao WS, Mahley RW, Taylor JM (1985): Apolipoprotein E mRNA is abundant in the brain and adrenal, as well as in the liver, and is present in other peripheral tissues of rat and marmosets. Proc Natl Acad Sci USA 82:203-207.
9. Fleming LM, Weisgraber KH, Strittmatter WJ, Troncoso JC, Johnson GV (1996): Differential binding of apolipoprotein E isoforms to tau and other cytoskeletal proteins. Exp Neurol 138:252-260.
10. Genis I, Gordon I, Sehayek E, Michaelson DM (1995): Phosphorylation of tau in apo E-deficient mice. Neurosci Lett 199:5-8.
11. Goedert M, Jakes R, Crowther RA, Six J, Luebke U, Vandermeeren M, Cras P, Trojanowski JQ, Lee VM-Y (1993): The abnormal phosphorylation of tau protein at serine 202 in Alzheimer Disease recapitulates phosphorylation during development. Proc Natl Acad Sci USA 90:5066-5070.
12. τ proteins display the same biochemical properties as normal τ. J Biol Chem 267:564-569.
13. Gruenstein E, Wang X (1996): The rapid neurotoxic effects of apolipoprotein E peptides depend on free radical formation. Soc Neurosci 22:2122.
14. Handelmann GE, Boyles JK, Weisgraber KH, Mahley RW, Pitas RE (1992): Effects of apolipoprotein E, beta-very low density lipoproteins, and cholesterol on the extension of neurites by rabbit dorsal root ganglion neurons in vitro. J Lipid Res 33:1677-1688.
15. Hardie DG (1993). "Protein Phosphorylation." Oxford: Oxford University Press, pp 109-119.
16. Hartmann H, Eckert A, Muller WE (1994): Apolipoprotein E and cholesterol affect neuronal calcium signalling: The possible relationship to beta-amyloid neurotoxicity. Biochem Biophys Res Commun 200:1185-1192.
17. Hasagewa M, Morishima-Kawashima M, Takio K, Suzuki M, Litani K, Ihara Y (1992): Protein sequence and mass spectrometric analyses of tau in the Alzheimer Disease brain. J Biol Chem 267:17047-17054.
18. Hoffman R, Lee VM-Y, Otvos L Jr. (1996): Identification and characterization of tau phosphopeptide epitopes recognized by anti-paired helical filament antibodies. Soc Neurosci Abst 26:975.
19. Holtzman DM, Pitas RE, Kilbridge J, Nayhan BP, Mahley RW, Bu G, Schwartz AL (1995): Low density lipoprotein receptor-related protein mediates apolipoprotein E-dependent neurite outgrowth in a central nervous system-derived cell line. Proc Natl Acad Sci USA 92:9480-9484.
20. Huang DY, Weisgraber KH, Strittmatter WJ, Mathew WD (1995): Interaction of apolipoprotein E with laminin increases neuronal adhesion and alter neurite morphology. Exp Neurol 136:251-257.
21. Innerarity TL, Pitas RE, Mahley RW (1979): Binding of arginine-rich (E) apoprotein after recombination with phospholipid vesicles to the low density lipoprotein receptors of fibroblasts. J Biol Chem 254:4186-4190.
22. Kamibayashi C, Estes R, Lickteig RL, Yang S-I, Craft C, Mumby MC (1994): Comparison of heterotrimeric protein phosphatase 2A containing different B subunits. J Biol Chem 269:20139-20148.
23. Kater SB, Mattson MP, Cohan C, Connor J (1988): Calcium regulation of the neuronal growth cone. Trends Neurosci 11:315-321.
24. Kosik KS, Orrechio LD, Bakalis S, Neve RL (1986): Developmentally regulated expression of specific tau sequences. Neuron 2:1289-1397.
25. Laemmli, UK (1970): Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685.
26. Lee G (1990): Tau protein: An update on structure and function. Cell Motil Cytoskel 15:199-20.3.
27. Lichtenberg-Kraag B, Mandelkow E-M, Biernat J, Steiner B, Schroter C, Gustke N, Meyer HE, Mandelkow E (1992): Phosphorylalion dependent epitopes of neurofilament antibodies on tau protein and relationship with Alzheimer tau. Proc Natl Acad Sci USA 89:5384-5388.
28. 2+-homeostasis in central neurons and astrocytes by apolipoprotein E and βA4. Soc Neurosci 22:257.
29. Mumby MC, Walter G (1993): Protein serine/threonine phosphatases: Structure, regulation, and function in cell growth. Physiol Rev 73:673-699.
30. Nathan BP, Bellosta S, Sanan DA, Weisgraber KH, Mahley RW, Pitas RE (1994): Differential effects of apolipoproteins E3 and E4 on neuronal growth in vitro. Science 264:850-852.
31. Otvos L, Feiner L, Szendrei GI, Goedert M, Lee VMY (1994): Monoclonal antibody PHF-1 recognizes tau Protein Phosphorylated at serine residues 396 and 404. J Neurosci Res 39:669-673.
32. Pitas RE, Boyles JK, Lee SH, Hui DY, Weisgraber KH (1987): Lipoproteins and their receptors in the central nervous system: Characterization of the lipoproteins in cerebrospinal fluid and identification of apolipoprotein B, E (LDL) receptors in the brain. J Biol Chem 262:14352-14360.
33. Richey PL, Siedlak SL, Smith MA, Perry G (1995): Apolipoprotein E interaction with the neurofibrillary tangles and senile plaques in Alzheimer disease: Implications for disease pathogenesis. Biocheml & Biophys Res Comm 208:657-663.
34. Richter A, Davies DE, Alexander P (1995): Growth inhibitory effects of FK506 and cyclosporin A independent of inhibition of calcineurin. Biochem Pharmacol 49:367-373.
35. Saunders AM, Strittmatter WJ, Schmechel D, St. George-Hyslop PH, Pericak-Vance MA, Joo SH, Rosi BL, Gusella JF, Crapper-MacLachlan DR, Alberts MJ, Hulette C, Crain B, Goldgraber D, Roses AD(1993): Association of apolipoprotein E allele apoE4 with late-onset familial and sporadic Alzheimer's disease. Neurology 43:1467-1472.
36. Selkoe DJ (1994): Alzheimer Disease: A central role for amyloid. J Neuropathol Exp Neurol 53:438-447.
37. Sontag E, Nunbhakdi-Craig V, Bloom GS, Mumby MC (1995): A novel pool of protein phosphatase 2A is associated with microtubules and is regulated during the cell-cycle. J Cell Biol 128:1131-1144.
38. Sontag E, Nunbhakdi-Craig V, Lee G, Bloom GS, Mumby MC (1996): Regulation of the phosphorylation state and microtubule-binding activity of tau by protein phosphatase 2A. Neuron 17:1201-1207.
39. Sparrow JT (1976): An improved polystyrene support for solid phase peptide synthesis. J Org Chem 41:1350-1353.
40. Strittmatter WJ, Saunders AM, Schmechel D, Pericak-Vance M, Enghild J, Salvesen GS, Roses AD (1993): Apolipoprotein E: High-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc Natl Acad Sci USA 90:1977-1981.
41. Towbin H, Staehelin T, Gordon J (1979): Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: Procedure and some applications. Proc Natl Acad Sci USA 76:4350-4354.
42. Wang X, Gruenstein E (1997): The rapid elevation of neuronal cytoplasmic calcium by apolipoprotein E peptide. J Cell Physiol, 173:73-83.
43. Wüstenberg F, Berlin K, Scharnagl H, März W, Ohm TG, Müller W (1996): Differentially elevated intracellular calcium levels by apoE-isoforms in the presence of βA4-amyloid. Soc Neurosci 22:257.
44. Zemlan FP, Dean GE (1996): Monoclonal antibody PHF-9 recognizes phosphorylated serine 404 of tau protein and labels paired helical filaments. J Neurosci Research 46:90-97.
45. Zemlan FP, Dean GE, Campbell TA (1997): Identification of cerebrospinal fluid-associated human tau proteins: ELISA development and characterization in patients with axonal degeneration. J Neurochem: in press.